HomeMarketsSharesOption Care Health Inc

Trade Option Care Health Inc - OPCH CFD

31.25+0.35%
The chart shows the OPCH stock price data over the last 1 day, with a current price of 31.25, a high of 31.22, and a low of 31.09.
Low: 31.09High: 31.22
Sellers:
0%
Buyers:
100%
Past performance is not a reliable indicator of future results. Share prices are indicative and may differ from live market prices.
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.09
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02221 %
(-$0.44)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $$1,000.00


-0.02221%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.00002 %
(-$0.00)

Trade size with leverage ~ $2,000.00

Money from leverage ~ $$1,000.00


-0.00002%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin50.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close31.15
Open31.18
1-Year Change12.4%
Day's Range31.09 - 31.22

Trade Option Care Health Inc - OPCH

About Option Care Health Inc

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company provides a therapy portfolio through its network of approximately 97 full-service pharmacies and 57 stand-alone ambulatory infusion suites. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. It contracts with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. It administers a range of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, women’s health and others. It also offers nursing platform that include specialty nursing resources to healthcare providers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Option Care Health Inc revenues increased 13% to $3.44B. Net income totaled $139.9M vs. loss of $8.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Total other expense decrease of 38% to $67M (expense), Other, net - Balancing value decrease of 53% to $10.8M (expense).

Equity composition

Common Stock $.0001 Par, 3/11, 125M auth., 57,063,496 issd., less 2,642,398 shs. in Treas. @ $10.6M. Insiders & strategic holders own 2.32%. IPO: 8/96, 4M shares @ $13 by PaineWebber Inc. 03/05, Co. acq. Chronimed Inc. @ 1.12 sh of BIOS (14,363,933 shs issd.) & also name changed from MIM Corporation following the merger.

Latest shares articles

BAE Systems stock forecast
BAE Systems stock forecast: H1 results, guidance upgrade
BAE Systems is a UK defence and aerospace group listed in London. In August 2026, it secured a $149.8m US Navy award for work on the USS Boxer. Explore third-party BA. price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:18, 16 October 2026
TAURON stock forecast
TAURON stock forecast: H1 earnings
TAURON is a Polish energy group. In the first half of 2026, revenue was broadly flat, while EBITDA and net profit fell amid higher CO2 allowance costs and coal consumption. Explore third-party analyst targets and technicals. Past performance is not a reliable indicator of future results.
12:04, 12 October 2026
Puma stock forecast
Puma stock forecast: Anta stake deal cleared
Puma is a German sportswear company. Chinese regulators have cleared Anta Sports’ proposed acquisition of an approximately 29% stake, with completion expected before the end of 2026. Explore third-party PUM price targets. Past performance is not a reliable indicator of future results.
10:19, 12 October 2026
Dino Polska stock forecast
Dino Polska stock forecast: H1 sales growth slows
Dino Polska is a Polish grocery retailer. In H1 2026, revenue rose 12.5% year on year to 18.0bn PLN, while like-for-like sales growth slowed to 2.2%. Explore third-party DNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
08:27, 12 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready